Skip to main content

Peer Review reports

From: Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China

Original Submission
2 Jul 2022 Submitted Original manuscript
9 Nov 2022 Reviewed Reviewer Report
28 Dec 2022 Reviewed Reviewer Report
19 Jan 2023 Author responded Author comments - Xiangli Cui
Resubmission - Version 2
19 Jan 2023 Submitted Manuscript version 2
29 Jan 2023 Reviewed Reviewer Report
6 Feb 2023 Reviewed Reviewer Report
24 Feb 2023 Author responded Author comments - Xiangli Cui
Resubmission - Version 3
24 Feb 2023 Submitted Manuscript version 3
28 Feb 2023 Author responded Author comments - Xiangli Cui
Resubmission - Version 4
28 Feb 2023 Submitted Manuscript version 4
19 Mar 2023 Reviewed Reviewer Report
19 Mar 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
4 Apr 2023 Editorially accepted
12 Apr 2023 Article published 10.1186/s12913-023-09365-z

You can find further information about peer review here.

Back to article page